We use cookies to so our web site can function correctly. By Clicking "OK" or by clicking into any content on this site, you agree to allow cookies to be placed. To find out more visit the cookies section of our privacy policy.

Privacy Statement

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

(Req)
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required

Functional

These cookies allow us to adtertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Marketing

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site.  All information collect is annonomas unless you provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Professor Robert Hawkins

MA, MB BS, PhD, FRCP

Consultant Medical Oncologist Manchester

Specialty
Sub-Specialties
  • Adrenal cancer, Kidney cancer, Melanoma, Soft tissue cancer
Fixed Price Packages

About

  • Biography icon plus

    After medical school at Cambridge University and University College London, Professor Hawkins trained in Medical Oncology at the Royal Marsden Hospital and Addenbrooke’s Hospital, Cambridge, and obtained a PhD in antibody engineering at the MRC Laboratory of Molecular Biology in Cambridge. He was Professor of Medical Oncology at the Christie Hospital from 1998 - 2019. His main clinical interests are in renal/adrenal cancers, focusing on immunotherapy as a treatment for cancer. . A particular specialty is the delivery of high dose interleukin-2 as a potentially curative treatment for selected patients with renal cancer.

    He also undertakes Phase I/II trials of immune and other biological therapies in a wider range of cancers including gastrointestinal cancers, melanoma and B cell lymphomas as well as renal cancers. Adoptive cellular therapy is the major translational research interest of Professor Hawkins who leads the EU ‘ATTACK’ programme and the EU ATTRACT training network (www.attack-cancer.org), which links leading European researchers in the engineered T-cell field. He has established a specialist Cellular Therapy Laboratory Unit in Manchester, which currently supports trials/treatments of cellular therapy for B-cell malignancies and melanoma. He has published widely on clinical/translational cancer research and is on several national and international clinical/translational research committees.

  • Clinical interests icon plus

    Kidney (renal) cancer; Malignant melanoma; Adoptive cell therapy; TIL therapy (tumour infiltrating lymphocyte therapy) for melanoma; Specialist in Immunotherapy; Expertise in high-dose interleukin-2 for kidney cancer

Practice locations

NHS base

The Christie NHS Trust

back to top